Equity Fundraising of £3 million

S-Ventures PLC – Equity Fundraising of £3 million RNS Number : 0665WS-Ventures PLC17 December 2021

17 December 2021


(“S-Ventures” or the “Company”)

Equity Fundraising of £3 million

S-Ventures PLC (UK: SVEN, USA: SVTPF) is pleased to announce that the Company has raised gross proceeds of approximately £3 million (the “Fundraising“) by way of an issue of 4,285,714 new Ordinary shares (“New Ordinary Shares“) at 70p per Share.

Each investor has been granted one warrant for every three New Ordinary Shares subscribed for, whereby each warrant will entitle the holder to subscribe for a new ordinary share at £2.00 per Share at any time prior to 20 December 2023. In total, the Company has granted 1,428,571 warrants which will be non-transferable.

The Company intends to use the proceeds of the Fundraising to accelerate its plans to grow and acquire natural food tech and wellness brands.

Application has been made for the New Ordinary Shares to be admitted to trading on the AQSE Growth Market and this is expected to occur on 23 December 2021 (“Admission”).

Following Admission, the issued share capital of the Company will be 116,819,911 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interests in, or change to their interest in, the Company under the FCA’s Disclosure and Transparency Rules

Commenting on the fundraise, Scott Livingston, CEO stated:

“It is an exciting time for the Company as we seek to accelerate our growth.  The sectors in which we are seeking to develop our brand strategy are experiencing many changes and this is presenting us with exciting opportunities.  These funds will enable the Company to move forward strongly”.

For further information, please contact:

The Company

Robert Hewitt  +44 (0) 1932 400 224

AQSE Corporate Adviser and Broker:

VSA Capital Limited

Andrew Raca/Pascal Wiese – Corporate Finance  +44 (0) 20 3005 5000

Andrew Monk (Corporate Broking)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.